Eone Diagnomics Genome Center Co., Ltd. Logo

Eone Diagnomics Genome Center Co., Ltd.

A healthcare company specializing in genetic analysis for personalized medicine.

245620 | KO

Overview

Corporate Details

ISIN(s):
KR7245620000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 갯벌로 143 -, 인천광역시

Description

Eone Diagnomics Genome Center (EDGC) is a healthcare company specializing in genetic analysis services. Utilizing Next-Generation Sequencing (NGS) and advanced bioinformatics, the company provides a range of clinical and consumer genetic tests. Its services span the entire life cycle, from the NICE® non-invasive prenatal test for fetal chromosomal abnormalities to the bebegene® newborn genetic screening test. For adults, EDGC offers the MYGENPLAN® integrated genotype and phenotype test for personalized healthcare guidance and the gene2me® Plus test, which predicts genetic risk for major cancers and general diseases. The company focuses on delivering clinical solutions for precision and personalized medicine, enabling disease prevention and customized care based on individual genetic information.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-04-10 00:00
주요사항보고서(회생절차개시신청)
Korean HTML 5.8 KB
2025-04-10 00:00
기타시장안내 (상장폐지 등 관련)
Korean HTML 5.5 KB
2025-04-10 00:00
주권매매거래정지기간변경 (상장폐지 사유발생, 회생절차 개시신청)
Korean HTML 5.9 KB
2025-04-09 00:00
기타경영사항(자율공시) (회생절차폐지결정에 대한 항고 취하)
Korean HTML 5.8 KB
2025-03-28 00:00
정기주주총회결과
Korean HTML 22.0 KB
2025-03-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean HTML 10.0 KB
2025-03-27 00:00
감사보고서제출
Korean HTML 25.9 KB
2025-03-27 00:00
기타시장안내 (상장폐지 관련)
Korean HTML 3.8 KB
2025-03-27 00:00
주권매매거래정지기간변경 (투자자보호)
Korean HTML 5.5 KB
2025-03-27 00:00
사업보고서 (2024.12)
Korean HTML 731.2 KB
2025-03-19 00:00
기타경영사항(자율공시) (감사보고서 제출 지연 사유)
Korean HTML 6.3 KB
2025-03-13 00:00
주주총회소집결의
Korean HTML 14.2 KB
2025-03-13 00:00
주주총회집중일개최사유신고
Korean HTML 5.2 KB
2025-03-13 00:00
주주총회소집공고
Korean HTML 203.5 KB
2025-02-28 00:00
[기재정정]내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Korean HTML 27.7 KB

Automate Your Workflow. Get a real-time feed of all Eone Diagnomics Genome Center Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eone Diagnomics Genome Center Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eone Diagnomics Genome Center Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.